Bank of America
CLDX icon

Bank of America’s Celldex Therapeutics CLDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$5.62M Buy
276,184
+31,248
+13% +$636K ﹤0.01% 3216
2025
Q1
$4.45M Buy
244,936
+202,088
+472% +$3.67M ﹤0.01% 3319
2024
Q4
$1.08M Sell
42,848
-175,590
-80% -$4.44M ﹤0.01% 4188
2024
Q3
$7.42M Sell
218,438
-28,673
-12% -$975K ﹤0.01% 2872
2024
Q2
$9.15M Sell
247,111
-24,500
-9% -$907K ﹤0.01% 2614
2024
Q1
$11.4M Buy
271,611
+53,797
+25% +$2.26M ﹤0.01% 2456
2023
Q4
$8.64M Buy
217,814
+5,557
+3% +$220K ﹤0.01% 2548
2023
Q3
$5.84M Sell
212,257
-142,664
-40% -$3.93M ﹤0.01% 2735
2023
Q2
$12M Sell
354,921
-6,596
-2% -$224K ﹤0.01% 2150
2023
Q1
$13M Buy
361,517
+208,217
+136% +$7.49M ﹤0.01% 2188
2022
Q4
$6.83M Buy
153,300
+22,310
+17% +$994K ﹤0.01% 2621
2022
Q3
$3.68M Buy
130,990
+49,268
+60% +$1.38M ﹤0.01% 3103
2022
Q2
$2.2M Sell
81,722
-99,172
-55% -$2.67M ﹤0.01% 3637
2022
Q1
$6.16M Buy
180,894
+86,457
+92% +$2.94M ﹤0.01% 2946
2021
Q4
$3.65M Buy
94,437
+68,077
+258% +$2.63M ﹤0.01% 3401
2021
Q3
$1.42M Buy
26,360
+13,668
+108% +$738K ﹤0.01% 4069
2021
Q2
$425K Sell
12,692
-3,441
-21% -$115K ﹤0.01% 4830
2021
Q1
$333K Buy
16,133
+4,301
+36% +$88.8K ﹤0.01% 5043
2020
Q4
$207K Sell
11,832
-3,052
-21% -$53.4K ﹤0.01% 4869
2020
Q3
$221K Buy
14,884
+14,831
+27,983% +$220K ﹤0.01% 4642
2020
Q2
$1K Sell
53
-45
-46% -$849 ﹤0.01% 6099
2020
Q1
$0 Sell
98
-117
-54% ﹤0.01% 6189
2019
Q4
$0 Sell
215
-43
-17% ﹤0.01% 6234
2019
Q3
$0 Buy
258
+43
+20% ﹤0.01% 6406
2019
Q2
$1K Buy
215
+139
+183% +$647 ﹤0.01% 6218
2019
Q1
$0 Sell
76
-1,369
-95% ﹤0.01% 6310
2018
Q4
$0 Sell
1,445
-32,085
-96% ﹤0.01% 6325
2018
Q3
$15K Sell
33,530
-86,181
-72% -$38.6K ﹤0.01% 5820
2018
Q2
$60K Sell
119,711
-34,405
-22% -$17.2K ﹤0.01% 5318
2018
Q1
$359K Buy
154,116
+45,296
+42% +$106K ﹤0.01% 4367
2017
Q4
$308K Sell
108,820
-23,186
-18% -$65.6K ﹤0.01% 4460
2017
Q3
$378K Buy
132,006
+28,173
+27% +$80.7K ﹤0.01% 4367
2017
Q2
$256K Sell
103,833
-30,300
-23% -$74.7K ﹤0.01% 4492
2017
Q1
$484K Buy
134,133
+9,865
+8% +$35.6K ﹤0.01% 4225
2016
Q4
$440K Buy
124,268
+33,689
+37% +$119K ﹤0.01% 4176
2016
Q3
$365K Sell
90,579
-31,955
-26% -$129K ﹤0.01% 4129
2016
Q2
$538K Sell
122,534
-74,260
-38% -$326K ﹤0.01% 3901
2016
Q1
$744K Buy
196,794
+71,203
+57% +$269K ﹤0.01% 3620
2015
Q4
$1.97M Sell
125,591
-37,712
-23% -$591K ﹤0.01% 3082
2015
Q3
$1.72M Buy
163,303
+30,466
+23% +$321K ﹤0.01% 3162
2015
Q2
$3.35M Buy
132,837
+32,960
+33% +$831K ﹤0.01% 2332
2015
Q1
$2.78M Sell
99,877
-7,178
-7% -$200K ﹤0.01% 2334
2014
Q4
$1.95M Buy
107,055
+2,879
+3% +$52.5K ﹤0.01% 2614
2014
Q3
$1.35M Buy
104,176
+30,782
+42% +$399K ﹤0.01% 2871
2014
Q2
$1.2M Sell
73,394
-2,711
-4% -$44.2K ﹤0.01% 2940
2014
Q1
$1.35M Buy
76,105
+8,294
+12% +$147K ﹤0.01% 2815
2013
Q4
$1.64M Buy
67,811
+61,005
+896% +$1.48M ﹤0.01% 2699
2013
Q3
$241K Sell
6,806
-6,404
-48% -$227K ﹤0.01% 3947
2013
Q2
$206K Buy
+13,210
New +$206K ﹤0.01% 4369